Safeplus International Holdings Ltd. (ACAI)

[b9molecule]

yes, jagman, your math is correct.
When will this product actually be on the market?
we don't know, but the 10Q says a product could be on the market 6 to 9 months after FDA approval. If a Biophan-coated BSX stent is fully developed and ready for testing, it could be on track for a 510 FDA approval, which would take about 6 months. So for now perhaps the answer is a year to 18 months for product shipment. There are other revenue opportunities that precede this, however. Biophan will get an annual maintenance fee, and milestone payments. I am assuming that a 510 approval is a milestone, so we could see several million dollars in revenue for that...in six months???? Just a guess, trying to hash out a timeline. And dont forget about other products, and also other deals with different companies. I, for one, think that BSX is already testing for 510 approval, but I have nothing on which to back that up, its just a hunch.